Alethea Capital Management’s Labcorp LH Stock Holding History

Alethea Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,862	Closed	-$450K	–	105
2021 Q3	$450K	Buy	+1,862	New	+$469K	0.4%	44

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alethea Capital Management's LH Position: Q4 2021 in Review

Alethea Capital Management sold out of Labcorp (LH) in Q4 2021, closing a stake of 1,862 shares — an estimated $450K sold.

Alethea Capital Management first reported a position in LH in Q3 2021 and held it in 1 quarter. The position peaked at $450K in Q3 2021. 1,061 funds tracked by Wall St. Rank hold LH as of Q4 2021.

Alethea Capital Management reported no remaining Labcorp position as of Q4 2021 after selling out during the quarter.
Alethea Capital Management sold 1,862 Labcorp shares in Q4 2021, an estimated $450K.
Alethea Capital Management first reported a position in Labcorp in Q3 2021 and held it in 1 quarter.
Alethea Capital Management's Labcorp position peaked at $450K in Q3 2021.
1,061 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.

Based on Alethea Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.